![Robert Hombach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/07/2026
Robert J.
Hombach currently serves as Independent Director at BioMarin Pharmaceutical, Inc. since 2017, Director at EDGe Surgical, Inc., Independent Director at Embecta Corp.
since 2022, Independent Director at Seaport Therapeutics, Inc. starting in 2025, and Industry Advisor at Agent Capital LLC.
Former roles include Independent Director at CarMax, Inc. from 2018 to 2022, Director at Naurex, Inc., Director at Loyola University Health System, President & Director at Baxter International Foundation, Independent Director at Aptinyx, Inc. from 2018 to 2023, Director at Surgical Innovation Associates, Inc. from 2017 to 2022, Independent Director at Henry Schein, Inc. from 2025 to 2026, Chief Financial Officer & Vice President at Baxter International, Inc. from 2011 to 2015, and Executive VP, Chief Operations & Financial Officer at Baxalta, Inc. from 2015 to 2016.
Education includes an undergraduate degree from The University of Colorado in 1988 and an MBA from Kellogg School of Management in 1997.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/06/2026 | 49.360 ( 0,03% ) | 3 M $ | 31/07/2026 | |
| 23/03/2026 | 5.421 ( 0% ) | 464 851 $ | 31/07/2026 | |
EMBECTA CORPORATION 0,18% | 12/08/2026 | 109.587 ( 0,18% ) | 398 897 $ | 31/07/2026 |
0,02% | 22/06/2026 | 13.000 ( 0,02% ) | 265 980 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Direttore/Membro del Consiglio | 29/09/2017 |
| EMBECTA CORP. | Direttore/Membro del Consiglio | 20/03/2022 |
EDGe Surgical, Inc.
 EDGe Surgical, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electronic depth gauge devices for orthopedic surgery | Direttore/Membro del Consiglio | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consulente / Consigliere | - |
| Società | Posizione | Fine |
|---|---|---|
| HENRY SCHEIN, INC. | Direttore/Membro del Consiglio | 21/05/2026 |
| APTINYX | Direttore/Membro del Consiglio | 30/06/2023 |
| CARMAX, INC. | Direttore/Membro del Consiglio | 28/06/2022 |
Surgical Innovation Associates, Inc.
 Surgical Innovation Associates, Inc. Medical SpecialtiesHealth Technology Manufactures and sells mono filament mesh for plastic and reconstructive surgery | Direttore/Membro del Consiglio | 01/01/2022 |
| BAXALTA INC | Direttore Finanziario/CFO | 01/06/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Henry Schein, Inc.
 Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
CarMax, Inc.
 CarMax, Inc. Specialty StoresRetail Trade Operates as a holding company whose subsidiaries retails and finance used motor vehicles | Retail Trade |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Health System
 Loyola University Health System Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Baxter International Foundation | |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Surgical Innovation Associates, Inc.
Surgical Innovation Associates, Inc. Medical SpecialtiesHealth Technology Manufactures and sells mono filament mesh for plastic and reconstructive surgery | Health Technology |
EDGe Surgical, Inc.
EDGe Surgical, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electronic depth gauge devices for orthopedic surgery | Electronic Technology |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Embecta Corp.
 Embecta Corp. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices for the treatment of diabetes | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
